ReviewACS organic & inorganic Au2024
Diazines and Triazines as Building Blocks in Ligands for Metal-Mediated Catalytic Transformations.
Review in ACS organic & inorganic Au, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Guest-Induced Vibration Locking and Fluorescence Switching in a Pyrene-Functionalized Covalent Organic Framework (COF) for Perfluorooctanoic Acid (PFOA) Recognition.Journal of the American Chemical Society · 2026Article
- How topology governs cation affinity: protonation and metal coordination in 1- and 9-azahomocubane.RSC advances · 2026Article
- Triazine-based cobalt pincer complex for regioselective C-H borylation of furans.Scientific reports · 2026Article
- Deuteration of Six-Membered N-Heteroarenes: Chemistry and Applications.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025Review
- Synthesis of Cyclobutane-Containing Tricyclic β-Lactams Based on a Saturated Scaffold Enabled by Iron-catalysed [2 + 2]-Cycloaddition.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025Article
- Palladium-catalyzed cascade of aza-Wacker and Povarov reactions of aryl amines and 1,6-dienes for hexahydro-cyclopenta[b]quinoline framework.Nature communications · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pyridine is a ubiquitous building block for the design of very diverse ligand platforms, many of which have become indispensable for catalytic transformations. Nevertheless, the isosteric pyrazine, pyrimidine, and triazine congeners have enjoyed thus far a less privileged role in ligand design. In this review, several applications of such fragments in the design of new catalysts are presented. In a significant number of cases described, diazine- and triazine-based ligands either outperform their pyridine congeners or offer alternative catalytic pathways which enable new reactivities. The potential opportunities unlocked by using these building blocks in ligand design are discussed, and the origin of the enhanced catalytic activity is highlighted where mechanistic studies are available.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.